Medicare and Medicaid
Featured Topics
Lead story
Other featured articles
-
Cancer Drug Shortages Result in Almost no Treatment Changes, USC Study Finds
Jacobson and Alpert studied more than 2.4 million monthly claims for chemotherapy treatment and found little impact on outpatient chemotherapy treatment for the majority of oncology drugs identified as experiencing shortages between 2004 and 2011.
-
Thirty-Day Postdischarge Mortality Among Black and White Patients 65 Years and Older in the Medicare Hospital Readmissions Reduction Program
In this study of patients 65 years and older, short-term postdischarge mortality did not appear to increase for black patients under the HRRP, suggesting that certain value-based payment policies can be implemented without harming black populations. However, mortality seemed to increase for white patients with HF and this situation warrants investigation.
Posted in -
Joint Recommendations of USC-Brookings Schaeffer Initiative for Health Policy and AEI Scholars to Reduce Healthcare Costs
The experts recommendations to the Senate committee aimed at four main goals: improving incentives in private insurance, removing state regulatory barriers to provider market competition, improving incentives in the Medicare program, and promoting competition in the pharmaceutical market.
Posted in -
A New Way to Pay for Innovative Drugs, Provide Universal Access and Not Break the Bank
Neeraj Sood penned an analysis of Louisiana's new path to curing hepatitis C among its Medicaid and prison populations. It is the first state to implement a solution proposed by Sood in a National Academies of Sciences consensus report and in a leading medical journal.
Posted in
About this section
The nation’s growing debt threatens Medicare and Medicaid, which have helped countless Americans and reduced poverty. Schaeffer Center researchers work with legislators on a bipartisan basis to bolster these vital systems, making them more efficient and effective.
Our Experts On Medicare and Medicaid
Our Work In Medicare and Medicaid
-
Ending Drug Rebates will Increase Medicare Part D Premiums, but Most Seniors will be Insulated From It
Erin Trish and Dana Goldman argue eliminating drug rebates will increase the cost of Medicare Part D premiums, but most seniors will be not feel the effects. They say seniors should ignore pharmacy benefit managers’ alarm raised by the proposal.
Categorized in -
Seminar Series: Carrie Colla
Carrie Colla is a health economist and an associate professor at The Dartmouth Institute for Health Policy and Clinical Practice. Her presentation will be on “Learning for Medicare ACOs: Policy to Practice.”
-
Improving The Medicare Physician Fee Schedule: Make It Part Of Value-Based Payment
To make greater strides towards value-based payment models in Medicare, Paul Ginsburg recommends that those who are testing alternative payment models at CMS should work directly with the team managing the existing fee-for-service payment system.
-
Reforming Stark/Anti-Kickback Policies
On January 30, U.S. Deputy Secretary of Health and Human Services Eric Hargan will visit Brookings to deliver remarks on reforming Stark/anti-kickback policies. After delivering his prepared remarks there will be a panel discussion including Kimberly Brandt from CMS.
Categorized in -
Characteristics of Physicians Excluded From US Medicare and State Public Insurance Programs for Fraud, Health Crimes, or Unlawful Prescribing of Controlled Substances
The number of physicians excluded from participation in Medicare and state public insurance reimbursement owing to fraud, waste, and abuse increased on average, 20 percent per year, between 2007 and 2017.
Categorized in -
Medicare Graduate Medical Education Funding is Not Addressing the Primary Care Shortage: We Need a Radically Different Approach
Schaeffer Initiative experts evaluate the impact of Medicare funding for hospitals, physicians and medical education on specialty selection by new doctors.